Signature Estate & Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,361
Closed -$302K 705
2026
Q1
$302K Hold
2,361
0.01% 536
2025
Q4
$288K Buy
2,361
+7
+0.3% +$803 0.01% 510
2025
Q3
$236K Buy
+2,354
New +$212K 0.01% 546
2024
Q4
Sell
-2,336
Closed -$231K 566
2024
Q3
$231K Buy
2,336
+125
+6% +$12.3K 0.01% 470
2024
Q2
$205K Buy
+2,211
New +$198K 0.01% 485
2020
Q1
Sell
-3,965
Closed -$377K 166
2019
Q4
$377K Hold
3,965
0.02% 121
2019
Q3
$302K Sell
3,965
-1,206
-23% -$100K 0.02% 132
2019
Q2
$454K Buy
5,171
+2,438
+89% +$208K 0.03% 116
2019
Q1
$247K Sell
2,733
-7,015
-72% -$597K 0.02% 144
2018
Q4
$699K Buy
9,748
+2,440
+33% +$197K 0.06% 108
2018
Q3
$701K Buy
7,308
+1,205
+20% +$117K 0.06% 96
2018
Q2
$581K Sell
6,103
-530
-8% -$48.7K 0.05% 104
2018
Q1
$582K Buy
6,633
+337
+5% +$30.8K 0.06% 103
2017
Q4
$534K Sell
6,296
-1,550
-20% -$130K 0.05% 113
2017
Q3
$679K Sell
7,846
-598
-7% -$47.9K 0.08% 96
2017
Q2
$652K Buy
8,444
+297
+4% +$21.1K 0.08% 81
2017
Q1
$565K Buy
8,147
+1,518
+23% +$102K 0.07% 87
2016
Q4
$392K Buy
6,629
+1,777
+37% +$110K 0.05% 91
2016
Q3
$322K Hold
4,852
0.05% 98
2016
Q2
$262K Buy
+4,852
New +$266K 0.04% 103

Other funds holding XBI

Signature Estate & Investment Advisors's XBI Position: Q2 2026 in Review

Signature Estate & Investment Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2026, closing a stake of 2,361 shares — an estimated $302K sold.

Signature Estate & Investment Advisors first reported a position in XBI in Q2 2016 and held it in 20 quarters. The position peaked at $701K in Q3 2018. 551 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Signature Estate & Investment Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2026 after selling out during the quarter.
  • Signature Estate & Investment Advisors sold 2,361 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $302K.
  • Signature Estate & Investment Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and held it in 20 quarters.
  • Signature Estate & Investment Advisors's State Street SPDR S&P Biotech ETF position peaked at $701K in Q3 2018.
  • 551 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Signature Estate & Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.